Baxter International Inc. ($BAX) Stock Forecast: Up 5.1% Today

What is Baxter International Inc.?

Baxter International Inc. (NYSE: BAX) is a global company that develops, manufactures, and markets medical products used in hospitals and healthcare facilities. Today, the stock of Baxter International Inc. experienced a strong bullish movement in the market.

Why is Baxter International Inc. going up?

BAX stock is up 5.1% on Nov 12, 2025 14:41

• Despite the pending class action lawsuits and reminders to shareholders, Baxter International Inc. saw a bullish trend, indicating that investors may have confidence in the company's ability to navigate through legal challenges.
• The market movement could be attributed to positive developments within the company that outweigh the legal uncertainties highlighted in recent discussions.
• Investors might be optimistic about Baxter International's future performance and potential growth prospects in the healthcare industry, leading to increased buying activity and driving the stock price higher.

BAX Price Chart

BAX Technical Analysis

BAX News

Levi & Korsinsky Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - BAX - Baxter Intl ( NYSE:BAX )

NEW YORK, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ( "Baxter International, Inc." or the "Company" ) ( NYSE:BAX ) of a class action securities lawsuit.

https://www.benzinga.com/pressreleases/25/11/g48792198/levi-korsinsky-reminds-baxter-international-inc-investors-of-the-pending-class-action-lawsuit-with

Baxter International Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the BAX Securities Class Action - Baxter Intl ( NYSE:BAX )

SAN DIEGO, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Company: Baxter International, Inc. ( NYSE:BAX ) is a global company that develops, manufactures, and markets medical products used in hospitals and other healthcare facilities. Class Period: February 23, 2022 and July 30, 2025

https://www.benzinga.com/pressreleases/25/11/g48788074/baxter-international-stockholders-with-large-losses-should-contact-robbins-llp-for-information-abo

The Gross Law Firm Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - BAX - Baxter Intl ( NYSE:BAX )

NEW YORK, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. ( NYSE:BAX ) . Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead ...

https://www.benzinga.com/pressreleases/25/11/g48764982/the-gross-law-firm-reminds-baxter-international-inc-investors-of-the-pending-class-action-lawsuit-

BAXTER INTERNATIONAL INC. ( NYSE: BAX ) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline - Baxter Intl ( NYSE:BAX )

NEW YORK, Nov. 10, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Baxter International Inc. ( NYSE:BAX ) ? Did you purchase your shares between February 23, 2022 and July 30, 2025, inclusive? Did you lose money in your investment in Baxter ...

https://www.benzinga.com/pressreleases/25/11/g48749699/baxter-international-inc-nyse-bax-deadline-alert-bernstein-liebhard-llp-reminds-baxter-internation

BAX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - Baxter Intl ( NYSE:BAX )

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options

https://www.benzinga.com/pressreleases/25/11/g48742149/bax-shareholder-action-reminder-faruqi-faruqi-llp-announces-that-baxter-investors-have-opportunity

Trending Today

Litecoin ($LTC) Crypto Forecast: Up 5.2% Today

Dogecoin ($DOGE) Crypto Forecast: Up 6.3% Today

Helmerich & Payne Inc. ($HP) Stock Forecast: Up 5.6% Today

Home Depot Inc. (The) ($HD) Stock Forecast: Down 5.3% Today

Rivian Automotive Inc. ($RIVN) Stock Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 5.0% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.0% Today

Pepe ($PEPE) Crypto Forecast: Up 5.6% Today

Ethereum ($ETH) Crypto Forecast: Up 5.6% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Up 6.5% Today

Baxter International Inc. Price History

08.10.2024 - BAX Stock was down 5.0%

• Despite exceeding third-quarter expectations in terms of earnings and sales, Baxter faced a stock decline due to reduced gross and operating margins.
• The aftermath of Hurricane Helene is predicted to have a financial impact on Baxter in the short term, potentially causing unease among investors and contributing to the downward movement.
• While a strong demand and favorable pricing environment were projected to boost Baxter's Q3 earnings, complications in the supply chain likely led to increased expenses, influencing the stock's drop.
• Investors, looking beyond revenue and EPS, may have lingering concerns about Baxter's future performance despite surpassing earnings estimates, which has added to the overall bearish sentiment in the market.

31.06.2025 - BAX Stock was down 21.0%

• Baxter International Inc. (BAX) experienced a significant bearish movement following its Q2 earnings report, where it missed both earnings and sales expectations.
• The company also revised its full-year EPS outlook downwards, leading to a lack of confidence among investors and a sharp decline in the stock price.
• The weaker gross margin reported by Baxter further added to the negative sentiment, causing shares to slide nearly 9% pre-market.
• The disappointing earnings results and lowered guidance suggest that Baxter may be facing challenges in its core segments, impacting investor perception and leading to the bearish market movement.

31.06.2025 - BAX Stock was down 19.7%

• The bearish movement in Baxter's stock today could be attributed to the market's reaction to the upcoming Q2 earnings report.
• Investors might be concerned about Baxter's ability to meet Wall Street's expectations for key metrics and deliver another solid quarter.
• The uncertainty surrounding the company's core segments' performance and the pressure to achieve modest growth could have contributed to the negative sentiment in the market.
• Traders might be reacting to the possibility of margin gains stabilizing after a recent recovery, which could impact Baxter's overall financial outlook and future growth prospects.

08.10.2024 - BAX Stock was down 5.1%

• Baxter surpassed expectations in its third-quarter financial performance, exceeding both earnings and sales forecasts. However, the stock declined as gross and operating margins contracted.
• The company's financial outlook was affected by Hurricane Helene's aftermath, raising concerns about its short-term prospects.
• While higher demand and pricing were anticipated to boost earnings, supply-chain challenges increased costs, influencing the stock's negative movement.
• Investors may have reacted poorly to the mix of positive financial results with margin contraction, contributing to the stock's bearish direction.

30.09.2025 - BAX Stock was down 14.2%

• There was a downward revision in Baxter International Inc.'s 2025 guidance, resulting in a notable decline in its stock value to a 52-week low.
• Despite exceeding expectations in its third-quarter earnings report, the company's reduced sales and EPS projections for 2025 influenced the negative market sentiment.
• Legal inquiries from Faruqi & Faruqi, LLP and a securities fraud class action lawsuit caution from Bernstein Liebhard LLP potentially heightened investor worries and further impacted the stock's performance.
• The stock faced a bearish trend following the mixed reactions to Baxter's Q3 earnings, which included surpassing earnings but missing sales targets, along with a downward adjustment in its 2025 EPS guidance.

30.09.2025 - BAX Stock was down 17.0%

• A looming deadline for a securities fraud class action lawsuit could have caused unease among investors, triggering a selloff of Baxter International Inc. shares.
• Weaknesses in the IV fluid and anesthesia segments, noted in the Q3 preview, may have raised concerns about the company's future revenue and earnings performance.
• Ongoing shareholder litigations and legal investigations might have heightened the negative sentiment surrounding Baxter International Inc., exerting downward pressure on its stock value.
• In sum, the intertwining factors of legal uncertainties, segment vulnerabilities, and shareholder disputes likely contributed to the bearish market movement witnessed in Baxter International Inc. today.

30.09.2025 - BAX Stock was down 14.8%

• Baxter International Inc. (BAX) surpassed Q3 earnings expectations but missed sales targets, prompting a downward revision of their 2025 EPS guidance.
• Despite positive performances in Pharma and Advanced Surgery, concerns arose among investors due to the overall sales miss and reduced EPS outlook, leading to a bearish market movement.
• The presence of an upcoming securities fraud class action lawsuit deadline and investor alerts may have further fueled negative sentiments around the company, impacting the stock price negatively.
• Investors are focusing on Baxter's core segments, notably Advanced Surgery and Drug Compounding, in the next quarter to evaluate the company's growth prospects in light of challenges faced by other product lines like IV fluids and anesthesia.

08.04.2025 - BAX Stock was up 5.3%

• The decline in short interest suggests growing investor confidence in Baxter Intl's future outlook.
• The positive market sentiment might be influenced by recent progress in healthcare, including treatment advancements and successful clinical trials.
• Investors could also be responding favorably to Baxter Intl's financial performance and strategic moves aimed at fostering growth.
• In summary, today's bullish movement in Baxter Intl's stock seems to stem from both reduced short interest and positive industry trends.

20.01.2025 - BAX Stock was up 8.9%

• Baxter's strong bullish movement today can be attributed to the better-than-expected Q4 adjusted EPS results, which exceeded both consensus estimates and the company's own guidance. This positive earnings report indicates that the company is performing well and has a solid financial outlook.
• The optimistic forecast for 2025 sales growth and adjusted EPS further boosted investor confidence in Baxter's future prospects, leading to increased buying interest in the stock.
• Despite the Q1 2025 EPS being projected below analyst estimates, the overall positive sentiment surrounding Baxter's performance and outlook likely overshadowed this minor concern, driving the stock price higher.
• Overall, Baxter's impressive financial results and optimistic guidance have propelled the stock to a bullish trajectory, reflecting investor optimism and confidence in the company's growth potential.

02.04.2025 - BAX Stock was down 5.0%

• Baxter exceeded sales expectations for medical devices in Q1, surpassing both internal projections and analyst forecasts.
• The optimistic guidance for 2025 should have instilled confidence in the company's future growth trajectory.
• Market volatility and unpredictability likely influenced profit-taking or broader concerns, leading to a decline in Baxter's stock value.
• Investor reactions to market conditions may have overshadowed the company-specific positive news, contributing to the stock's downward movement.

12.10.2025 - BAX Stock was up 5.1%

• Despite the pending class action lawsuits and reminders to shareholders, Baxter International Inc. saw a bullish trend, indicating that investors may have confidence in the company's ability to navigate through legal challenges.
• The market movement could be attributed to positive developments within the company that outweigh the legal uncertainties highlighted in recent discussions.
• Investors might be optimistic about Baxter International's future performance and potential growth prospects in the healthcare industry, leading to increased buying activity and driving the stock price higher.

31.09.2025 - BAX Stock was down 5.4%

• Today's downward trend in Baxter International Inc. (BAX) stock may be linked to the following factors:
• A pending securities fraud class action lawsuit by The Gross Law Firm has caused apprehension among investors, resulting in a decrease in confidence and a sell-off of shares.
• Baxter has revised its annual outlook and lowered its 2025 guidance on multiple occasions, which might have negatively impacted investor sentiment, with the stock hitting a 52-week low after the latest adjustment in guidance.
• Despite Baxter's Q3 earnings surpassing expectations, the stock dropped due to a sales shortfall and a downward revision in the 2025 EPS forecast, suggesting potential challenges in revenue generation ahead.
• Ongoing investigations and shareholder alerts by legal firms like Faruqi & Faruqi, LLP and Bernstein Liebhard LLP have contributed to the overall uncertainty surrounding the company, potentially influencing the bearish market movement.